摘要
目的探讨HIV/AIDS免费抗病毒治疗效果及影响因素。方法导出2015年1月-2018年12月该院坚持接受抗病毒治疗HIV/AIDS患者资料1 200例,对资料进行回顾性分析,探讨影响抗病毒治疗效果因素,并比较治疗前、治疗6、12个月后患者体内CD4+T淋巴细胞数量。结果经分析,年龄、CD4+T淋巴细胞基线水平、漏服药物等因素为影响HIV/AIDS免费抗病毒疗效主要因素,治疗前,HIV/AIDS患者CD4+T淋巴细胞数为(243.57±131.57)个/μL,经治疗6个月为(364.59±155.18)个/μL,治疗12个月后为(378.42±176.98)个/μL,相比治疗前,患者CD4+T淋巴细胞数治疗后数值上升明显,与治疗前相比,治疗6个月、12个月后差异有统计学意义(t1=14.78、t2=9.31,P<0.05)。结论应用抗病毒治疗能够稳定HIV/AIDS者病情,其影响因素主要为接受抗病毒治疗年龄、CD4+T淋巴细胞基线水平、漏服药物等,在开展抗病毒治疗过程中,应重视上述因素,予以适当措施,以稳定患者病情。
Objective To investigate the effect and influence factors on free antiviral therapy for HIV/AIDS. Methods Data of 1200 patients who insisted on receiving antiviral therapy for HIV/AIDS in the hospital from January 2015 to December2018 were exported and retrospective analyzed. The influence factors on the effect of antiviral therapy were investigated.The counts of CD4+T cells before therapy and 6 months and 12 months after therapy were compared. Results After analysis,factors such as age, baseline levels of CD4+T lymphocytes, and missed medications were the main factors affecting the free antiviral efficacy of HIV/AIDS. Before treatment, the number of CD4+T lymphocytes in HIV/AIDS patients was(243.57±131.57)/μL,(364.59±155.18) cells/μL after 6 months of treatment, and(378.42±176.98) cells/μL after 12 months of treatment. Compared with before treatment, the number of patients with CD4 +T lymphocytes increased significantly after treatment, and Compared with before treatment, the difference was statistically significant after 6 months and 12 months of treatment(t1=14.78, t2=9.31, P<0.05). Conclusion The application of antiviral therapy can stabilize the condition of patients with HIVS/AIDS. The major influence factors are the age of receiving antiviral therapy, baseline level of CD4+T cells and missed doses. During the antiviral therapy, attention should be paid to the above factors and appropriate measures should be taken to stabilize the patient’s condition.
作者
江渊
JIANG Yuan(Department of Infectious Diseases,Yulin Red Cross Hospital,Guangxi Province,53700 China)
出处
《中外医疗》
2020年第3期81-83,共3页
China & Foreign Medical Treatment